Overview of Clik

Property	Description
Active ingredient	Dicyclanil (INN)
Form	Ready-to-use Pour-on Suspension
Pharmacological class	Ectoparasiticide / Insect Growth Regulator (IGR)
Origin	Synthetic (Pyrimidine derivative)
General purpose	Prophylactic control of external parasites

What is Clik and What Pharmacological Class Does it Belong To?

Clik is a veterinary medicinal product defined by its single active component, Dicyclanil, a synthetic compound utilized for external parasite management. Dicyclanil is an Antiparasitic agent and belongs to the chemical class of pyrimidine derivatives. The active compound is clinically recognized for its efficacy against specific infestations in target species. Its pharmacological identity as an Ectoparasiticide and an Insect Growth Regulator (IGR) establishes it as a specialized agent for combatting pests that reside on the host's exterior, offering targeted protection.

Composition and Pharmaceutical Form of Clik

The product is uniquely formulated as a ready-to-use pour-on suspension, a specialized preparation developed for topical, external use. The Dicyclanil active ingredient is delivered within an aqueous vehicle using advanced suspo-emulsion technology, a feature differentiating it from simple alcohol or oil solutions by ensuring uniform stability and persistence on the fleece. This pour-on format is characteristic of medications intended to provide long-lasting surface coverage following a single application.

General Purpose: Why is Dicyclanil Used?

The primary purpose of Clik is to provide prophylactic protection by utilizing Dicyclanil’s mechanism as an Insect Growth Regulator. This mechanism involves interrupting the physiological life cycle of specific ectoparasitic insect larvae, primarily by preventing the critical stages of moulting and pupation. Blocking the development of the pest population offers extended, reliable protection, helping to maintain the animal's overall health and prevent the establishment of severe external parasitic challenges. The general benefit is the sustained control of pests before they can reach maturity and cause widespread damage.

Regulatory References

European Medicines Agency

What side effects are possible with Clik?

Possible Side Effects and Safety Information

The safety profile for Clik (Dicyclanil) is defined by its regulatory classification for use in the target species (sheep), where official documents state that adverse reactions, in terms of both frequency and seriousness, are none known when the product is administered according to label instructions. This classification means no side effects are formally listed under standard frequency categories (e.g., common, uncommon, rare) in official regulatory texts.

Official Safety Restrictions and Limitations

The medicine's safety profile is primarily structured around high-level constraints and contraindications, rather than reported adverse reactions. These limitations are strictly defined in governmental regulatory documents.

Category	Regulatory Status
Adverse Reactions Scope	None known in the target species under normal use.
Contraindication	Use is strictly prohibited in cases of hypersensitivity to the active substance (Dicyclanil) or to any of the excipients.
Special Populations	Safety is not established during pregnancy or lactation.
Milk Production	The product is contraindicated for use in sheep producing milk for human consumption.

Safety Context and Use Limitations

Official documents indicate that the product, even at doses up to at least four times the recommended amount, does not lead to any signs of local or systemic intolerance in the target species, establishing a significant safety margin. However, high-level environmental safety notes are included, warning that the product poses a serious risk to aquatic life and has harmful effects on dung fauna, necessitating precautions to prevent water contamination.

This framework ensures that the safety description remains strictly descriptive of official regulatory content, focusing on established restrictions and the absence of documented adverse reactions.

Overdose and Emergency Response

The official regulatory profile for Clik (Dicyclanil), based strictly on government documentation, addresses overdose through established safety margins and mandated emergency actions for human exposure.

Overdose Scope and Clinical Manifestations

Official regulatory studies demonstrate a high tolerance in the target species (sheep). Administration of doses up to 20 times the recommended therapeutic amount does not lead to any documented signs of local or systemic intolerance. No specific adverse effects on physiological systems are documented in the regulatory overdose section for the target animal following these extreme dose levels.

Overdose Status	Official Regulatory Finding
Tolerance	No local or systemic intolerance documented in the target species up to 20x the therapeutic dose.
Antidote	No specific antidote is known.

Required Emergency Action

Due to the stated absence of a specific antidote, the regulatory mandates for accidental human exposure are critical. In the event of accidental ingestion, the official labeling requires the individual to seek medical advice immediately and present the product label or leaflet to the physician. Furthermore, if the product makes accidental contact with the eyes, rinsing with clean water must be performed, followed by contacting a physician for advice. These specific instructions define the conditions under which urgent medical help must be sought.

Therapeutic Uses of Clik

What Clik Treats: Main Uses and Benefits

Clik is commonly used to address infectious conditions and the resulting symptomatic burden. This application is relevant across several common domains involving the management of symptoms related to various infections. These include symptomatic support for conditions presenting with systemic or localized discomfort, such as those affecting the respiratory system, skin, and oral areas.

Symptom Management in Acute Bacterial Infections

Clik is commonly used to address symptom clusters that may become intense or disruptive related to acute bacterial infections. It helps address symptoms—such as fever, severe localized pain, and inflammation—that create noticeable physiological strain. The key benefit provides support that helps ease the overall symptom burden, supports patients during episodes of heightened discomfort and assists with maintaining functional stability.

Supportive Management in Chronic or Complex Conditions

The medication is applicable in specific contexts where additional symptomatic support is needed for conditions marked by recurrent or focused symptom patterns. This includes its use as a component in multi-drug regimens for H. pylori infection (gastric ulcers). Clik's role in this domain is relevant for easing distressing symptoms by addressing the microbial source, and contributes to improved comfort during periods of heightened symptoms.

Quick Facts

Relief for: Symptoms related to inflammatory or irritative states.
Used for: Conditions presenting with systemic or localized discomfort.
Benefit: Provides supportive relief when symptoms interfere with routine activities.

Proactive Comfort and Protection (Veterinary Prophylaxis)

The veterinary application of Clik is relevant for managing the risk of blowfly strike in sheep. This product is applied in scenarios where additional management of discomfort is required, which supports general well-being during symptomatic phases and assists with maintaining functional stability during periods of high risk.

Regulatory References

NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Clik?

The population eligibility for the veterinary medicine Clik (Dicyclanil) is strictly defined by regulatory documents, focusing on the target species, sheep.

Absolute Non-Eligibility (Contraindications)

Official labeling specifies two groups of animals that must not receive this product:

Sheep producing milk for human consumption are strictly contraindicated for use with Clik.
Sheep with known hypersensitivity (allergy) to the active substance, Dicyclanil, or any of its excipients.

Restricted and Conditional Use

Use of Clik in other specific populations requires conditional approval or has limitations:

Pregnant or Lactating Ewes: Safety has not been established during pregnancy or lactation (when milk is not intended for human consumption). Use is only permitted following a benefit/risk assessment by the responsible veterinarian.
Lambs: Efficacy is not established in lambs weighing less than 10 kg.
Environmental Constraint: Application is not recommended during expected or actual heavy rainfall to maintain the product's protective duration.

Eligible Population

Clik is authorized for use in sheep that do not fall under the absolute contraindications or other conditional use requirements.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Regulatory Status of Systemic Interactions

Official government regulatory documentation, including the Summary of Product Characteristics (SPC) from European authorities, defines the systemic interaction profile of Dicyclanil as having None known drug-drug interactions. This determination applies to all forms of systemic interaction, including those that might alter the plasma concentration or exposure of Dicyclanil, as well as potential pharmacodynamic effects with other medicinal products.

Interaction Type (as per regulatory documents)	Official Status in Label
Drug-Drug Interactions (Systemic)	None known
Pharmacokinetic Interactions (Metabolic/Transporter)	None documented
Food, Alcohol, or Herbal Product Interactions	None documented

Formal Interaction-Related Restrictions

The regulatory profile for Dicyclanil, however, includes a specific procedural constraint categorized as a Major Incompatibility concerning the product's physical form. This rule mandates that the ready-to-use pour-on suspension must not be mixed with any other veterinary medicinal product. This restriction is based solely on the absence of formal compatibility studies, which prohibits the co-mingling of products prior to administration.

Overall Interaction Profile

No medicinal products are listed as contraindicated or restricted due to a systemic interaction with Dicyclanil. The structure of the official interaction profile is characterized by the absence of known metabolic or pharmacodynamic interactions and is solely constrained by the non-mixing rule for the product's physical preparation.

Mechanism of Action

Inhibition of Larval Development Cascade

Clik (active ingredient dicyclanil) works within the insect growth regulation domain, specifically targeting the developmental pathways of blowfly larvae (Lucilia spp.). The molecule functions as a moulting inhibitor, disrupting the critical molecular and hormonal cascade that allows the first-stage larva to successfully shed its cuticle and progress to the larger, tissue-damaging second stage. This immediate developmental block leads to the death of the larvae and is the core mechanism that terminates larval development.

Persistent Topical Action in the Fleece System

The drug's mechanism is further defined by its long-term topical persistence within the fleece and skin surface system of the host. The formulation utilizes components that bind to the lanolin and suint (wool grease), creating a localized reservoir of the active ingredient. This sustained, external mechanism ensures that dicyclanil remains in the blowfly's feeding zone for an extended period, which facilitates sustained exposure to newly hatched larvae, thereby limits larval penetration and activity.

Dosage and Administration Information

Administration Scope

Clik is a ready-to-use pour-on suspension containing Dicyclanil, which is administered through the topical route for external use only. It is applied as a single treatment before or at the start of anticipated fly activity to provide extended protection for up to 16 weeks, depending on the product concentration.

Labeled Dosing Regimens (50 mg/mL Strength)

The dose is weight-based and requires accurate determination of the animal's mass to prevent under- or overdosing.

Body Weight (kg)	Dose Volume (mL)
10-20	20
21-30	25
31-50	30
>50	35

(Guide dose volumes for the 50 mg/mL formulation correspond to 0.6–2 mL per kg body weight).

Procedural and Environmental Conditions

Preparation: The container must be shaken well immediately prior to use to ensure homogeneity of the suspension; dilution with water is not permitted.

Application: The product must be applied using a manual or automatic dosing gun fitted with a fan spray nozzle to ensure proper spreading across the fleece. The application involves a four-stroke technique where half the total dose is applied along the spine and the remainder is applied over the crutch and tail area.

Constraints: Application should be avoided during heavy rainfall or when such conditions are expected, as this may reduce the product's effectiveness. Animals with dirty hindquarters should be dagged (trimmed) before administration, and if dagging occurs in the weeks following application, re-treatment of those animals is specified. Furthermore, sheep should not be shorn in the 3 months after treatment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Clik

Evidence for Prophylactic Control of Blowfly Strike

The research concerning Clik (Dicyclanil) is built primarily upon Randomized Controlled Field Trials where researchers observed treated animals alongside untreated control groups. The main goal of this research was to examine the measured time interval observed before the initial establishment of blowfly strike. The evidence base monitored outcomes related to the time interval over which treated animals were observed in studies monitoring infestation status.

Studies explored the Duration of Protection, tracking patterns observed in the animals over defined time intervals. Researchers also monitored the Cumulative Strike Rate, which describes the group patterns of how many animals developed a strike over the study period compared to untreated groups. Findings describe patterns observed in the studies that were used to contextualize the research landscape for this type of prophylactic control.

Studies in Diverse Conditions and Understanding Limitations

Research examined extended follow-up durations in controlled trials, with some observation periods reaching up to 21 to 29 weeks. These long-term studies contribute to understanding the duration of measured outcomes throughout a typical high-risk fly season.

Research explored how the treatment behaved across different types of sheep and with varying wool conditions. Research also included specialized studies that monitored the product's effect against diverse insect strains. Findings indicate that studies monitored larval development when challenged with field-derived strains that may have developed resistance to similar compounds.

Despite the evidence from controlled trials, certain limitations remain. Research describes that the duration of protection was observed to be shorter when studies challenged the treatment using strains of blowflies documented to have developed resistance to Dicyclanil. Findings describe that the measured protection intervals reported in trials may vary; research indicates that the level of resistance varies geographically.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Clik (FAQ)

Q: Why is Clik prescribed instead of another common drug?

A: According to regulatory documents, the drug is utilized for the prophylactic control of blowfly strike. Its active ingredient, dicyclanil, functions by interrupting the larval moulting process, which is the core mechanism of action defined in the label. This specific action is described as preventing the critical progression of first-stage larvae to the more damaging second stage.

Q: How quickly should someone expect Clik to start working?

A: The active ingredient functions as a moulting inhibitor, which is described as disrupting the developmental process of the targeted larvae. This mechanism prevents the critical progression to the damaging stage, as detailed in the product’s pharmacological documents.

Q: How long does the effect of one dose of Clik typically last?

A: Official regulatory information indicates that the product provides extended protection for a period of up to 16 weeks. Studies have noted that the measured duration may show variability based on environmental or application conditions in field settings.

Q: Can Clik affect blood sugar levels?

A: The official safety profile for the product states that adverse reactions, including effects on metabolism or blood sugar, are none known in the target species. This determination applies when the product is administered according to label instructions.

Q: How long after stopping Clik does the drug stay in the body?

A: The formulation is designed for long-term topical persistence on the fleece, with minimal systemic absorption of the active ingredient. Studies on the target species indicate that the highest residue half-lives (the time taken for half the substance to be eliminated) were found to be 13 days in the liver and 10 days in the kidney.

Q: What is the maximum duration of treatment with Clik based on official guidance?

A: The product is regulated as a single, seasonal treatment for prophylactic control, providing extended protection for up to 16 weeks following one application. Official constraints include a rule stating that the target animals must not be shorn in the 3 months following treatment.

Q: Can Clik cause weight gain or weight loss?

A: Regulatory safety documentation indicates that adverse reactions, including effects related to body weight, are none known in the target species when the product is used as directed.

Q: What are some of the most common reported side effects of Clik?

A: According to the official regulatory safety profile, adverse reactions, in terms of both frequency and seriousness, are formally designated as none known in the target species when used under normal conditions.

Q: Are the side effects of Clik generally mild?

A: Regulatory documents state that adverse reactions are none known in the target species. Furthermore, official documents note that even at doses up to at least four times the recommended amount, the product did not lead to signs of local or systemic intolerance.

Q: Is it normal to feel a bit tired when first starting Clik?

A: Regulatory documentation indicates that adverse reactions, including common symptoms such as tiredness or lethargy, are none known in the target species when the product is administered according to label instructions.

Q: Does Clik have any known severe side effects I should know about?

A: The official safety profile states that adverse reactions, in terms of both frequency and seriousness, are none known in the target species when the product is administered as directed.

Q: Does Clik affect birth control or hormone replacement therapy?

A: Official government regulatory documentation defines the systemic interaction profile as having None known drug-drug interactions. The label is solely constrained by a non-mixing rule related to the physical preparation of the product.

Q: Is it safe to drink coffee or caffeine while taking Clik?

A: According to the official regulatory interaction profile, interactions with food, alcohol, or herbal products such as caffeine are none documented.

Q: Does Clik cause changes in mood or anxiety levels?

A: Regulatory safety documentation indicates that adverse reactions, including changes in behavior or mood, are none known in the target species when the product is used as directed.

Q: What should be done if a person forgets to take a dose of Clik?

A: The product is a single-use prophylactic treatment applied seasonally. The official label notes that if the treated area is significantly trimmed (dagging/crutching) in the weeks following application, re-treatment of those specific animals is required.

Q: Can Clik affect sleep patterns?

A: Official regulatory documentation indicates that adverse reactions, including effects on sleep patterns or rest, are none known in the target species when the product is administered according to label instructions.

Q: What were the primary outcomes measured in the clinical trials for Clik?

A: Clinical trials focused on assessing the duration of protection, which is the measured time interval observed before the initial establishment of blowfly strike. Researchers also monitored the cumulative strike rate, which describes the group patterns of how many animals developed a strike over the study period.

Q: Can Clik cause dry mouth or changes in taste?

A: Regulatory safety documentation indicates that adverse reactions, including effects such as dry mouth or changes in taste, are none known in the target species when the product is used as directed.

Q: Has Clik been approved in countries other than the US?

A: Official documents, such as the Summary of Product Characteristics (SmPC) from European authorities, indicate that the product is authorized for use in the European Union and the United Kingdom.

Q: Are there studies comparing Clik's effect on quality of life?

A: Research focused on practical outcomes such as the duration of protection and cumulative strike rate related to infestation status. Studies did not include quality of life as a formal, measured outcome.

Q: Why is patient compliance important when taking Clik?

A: Regulatory guidance emphasizes that compliance with the application and post-treatment constraints is essential because the protective duration of the product may be reduced if instructions are not followed. Examples of constraints include avoiding application during expected heavy rainfall or not shearing the animals for a specified period after use.

Q: Does taking Clik at a specific time of day make a difference?

A: The official administration instructions for the single, seasonal prophylactic treatment do not specify a required time of day for application. The product is specified for application before or at the start of anticipated fly activity.

Q: Is Clik known to cause stomach upset?

A: Regulatory safety documentation indicates that adverse reactions, including gastrointestinal effects such as stomach upset, are none known in the target species when the product is used as directed.

Q: How does Clik affect the liver?

A: The active substance is primarily designed for topical action. After minimal systemic absorption, the substance is distributed in the body. Studies indicated that residues found in the liver of the target species were observed to have a half-life of 13 days.

Q: Is it normal for the color of Clik tablets to vary slightly?

A: The pharmaceutical form of the product is described in the regulatory documents as a ready-to-use pour-on suspension, not a tablet. It is described as a pink-coloured liquid suspension.

How should Clik be stored and disposed of?

Official Storage and Disposal Requirements

Clik must be stored and disposed of according to the specific instructions provided on the regulatory label to maintain its effectiveness and safety.

Storage Conditions

Requirement	Official Statement
Temperature	Store below 25 C (77 F). Do not freeze.
Protection	Keep the medicine in its original container, protected from moisture and light.
Child Safety	Always keep Clik out of the sight and reach of children.
Stability	Do not use the medicine after the expiry date printed on the carton.

Disposal Rules

Do not dispose of unused or expired Clik in household waste or pour it down a sink or toilet. Follow official guidelines by returning the medicine to a pharmacy take-back program or a designated collection point. This protects the environment and prevents improper use.

Clik